The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus

Early Chronic Kidney Disease (CKD) is a condition that tends to progress to End-Stage Kidney Disease (ESKD). Early diagnosis of kidney disease in the early stages can reduce complications. Alterations in renal function represent a complication of diabetes mellitus (DM). The mechanisms underlying the...

Full description

Bibliographic Details
Main Authors: Jorge Andrade-Sierra, Leonardo Pazarín-Villaseñor, Francisco Gerardo Yanowsky-Escatell, Elodia Nataly Díaz-de la Cruz, Andrés García-Sánchez, Ernesto Germán Cardona-Muñoz, Francisco Javier Munguía-Galaviz, Alejandra de Alba-Razo, Alejandra Guillermina Miranda-Díaz
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/19/11196
_version_ 1797479170304901120
author Jorge Andrade-Sierra
Leonardo Pazarín-Villaseñor
Francisco Gerardo Yanowsky-Escatell
Elodia Nataly Díaz-de la Cruz
Andrés García-Sánchez
Ernesto Germán Cardona-Muñoz
Francisco Javier Munguía-Galaviz
Alejandra de Alba-Razo
Alejandra Guillermina Miranda-Díaz
author_facet Jorge Andrade-Sierra
Leonardo Pazarín-Villaseñor
Francisco Gerardo Yanowsky-Escatell
Elodia Nataly Díaz-de la Cruz
Andrés García-Sánchez
Ernesto Germán Cardona-Muñoz
Francisco Javier Munguía-Galaviz
Alejandra de Alba-Razo
Alejandra Guillermina Miranda-Díaz
author_sort Jorge Andrade-Sierra
collection DOAJ
description Early Chronic Kidney Disease (CKD) is a condition that tends to progress to End-Stage Kidney Disease (ESKD). Early diagnosis of kidney disease in the early stages can reduce complications. Alterations in renal function represent a complication of diabetes mellitus (DM). The mechanisms underlying the progression of CKD in diabetes could be associated with oxidative and inflammatory processes. This study aimed to evaluate the state of inflammation and oxidative stress (OS) on the progression of CKD in the early stages in patients with and without type 2 diabetes mellitus (T2DM). An analytical cross-sectional study was carried out in patients with CKD in early stages (1, 2, 3) with and without T2DM. The ELISA method determined the expression of pro-inflammatory cytokines IL-6 and TNF-α as well as lipoperoxides (LPO), nitric oxide (NO), and superoxide dismutase activity (SOD). Colorimetric methods determined glutathione peroxidase (GPx) and total antioxidant capacity (TAC). Patients with CKD and T2DM had significantly decreased antioxidant defenses for SOD (<i>p</i> < 0.01), GPx (<i>p</i> < 0.01), and TAC (<i>p</i> < 0.01) compared to patients without T2DM. Consequently, patients with T2DM had higher concentrations of oxidant markers, NO (<i>p</i> < 0.01), inflammation markers, IL-6 (<i>p</i> < 0.01), and TNF-α than patients without T2DM. CKD stages were not related to oxidative, antioxidant, and inflammatory marker outcomes in T2DM patients. Patients without T2DM presented an increase in SOD (<i>p</i> = 0.04) and a decrease in NO (<i>p</i> < 0.01) when the stage of CKD increased. In conclusion, patients with T2DM present higher levels of oxidative and inflammatory markers accompanied by a decrease in antioxidant defense. However, these oxidative status markers were associated with CKD stage progression in patients without T2DM. Thus, NO and SOD markers could help detect the early stages of CKD in patients who have not yet developed metabolic comorbidities such as T2DM.
first_indexed 2024-03-09T21:42:32Z
format Article
id doaj.art-c3917f65290740108439a556eea0fc47
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T21:42:32Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-c3917f65290740108439a556eea0fc472023-11-23T20:28:56ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-09-0123191119610.3390/ijms231911196The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes MellitusJorge Andrade-Sierra0Leonardo Pazarín-Villaseñor1Francisco Gerardo Yanowsky-Escatell2Elodia Nataly Díaz-de la Cruz3Andrés García-Sánchez4Ernesto Germán Cardona-Muñoz5Francisco Javier Munguía-Galaviz6Alejandra de Alba-Razo7Alejandra Guillermina Miranda-Díaz8Nephrology Service, Department of Internal Medicine, Civil Hospital of Guadalajara “Dr Juan I. Menchaca”, Guadalajara 44340, Jalisco, MexicoNephrology Service, Department of Internal Medicine, Civil Hospital of Guadalajara “Dr Juan I. Menchaca”, Guadalajara 44340, Jalisco, MexicoNephrology Service, Department of Internal Medicine, Civil Hospital of Guadalajara “Dr Juan I. Menchaca”, Guadalajara 44340, Jalisco, MexicoDepartment of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara 44340, Jalisco, MexicoDepartment of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara 44340, Jalisco, MexicoDepartment of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara 44340, Jalisco, MexicoDepartment of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara 44340, Jalisco, MexicoDepartment of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara 44340, Jalisco, MexicoDepartment of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara 44340, Jalisco, MexicoEarly Chronic Kidney Disease (CKD) is a condition that tends to progress to End-Stage Kidney Disease (ESKD). Early diagnosis of kidney disease in the early stages can reduce complications. Alterations in renal function represent a complication of diabetes mellitus (DM). The mechanisms underlying the progression of CKD in diabetes could be associated with oxidative and inflammatory processes. This study aimed to evaluate the state of inflammation and oxidative stress (OS) on the progression of CKD in the early stages in patients with and without type 2 diabetes mellitus (T2DM). An analytical cross-sectional study was carried out in patients with CKD in early stages (1, 2, 3) with and without T2DM. The ELISA method determined the expression of pro-inflammatory cytokines IL-6 and TNF-α as well as lipoperoxides (LPO), nitric oxide (NO), and superoxide dismutase activity (SOD). Colorimetric methods determined glutathione peroxidase (GPx) and total antioxidant capacity (TAC). Patients with CKD and T2DM had significantly decreased antioxidant defenses for SOD (<i>p</i> < 0.01), GPx (<i>p</i> < 0.01), and TAC (<i>p</i> < 0.01) compared to patients without T2DM. Consequently, patients with T2DM had higher concentrations of oxidant markers, NO (<i>p</i> < 0.01), inflammation markers, IL-6 (<i>p</i> < 0.01), and TNF-α than patients without T2DM. CKD stages were not related to oxidative, antioxidant, and inflammatory marker outcomes in T2DM patients. Patients without T2DM presented an increase in SOD (<i>p</i> = 0.04) and a decrease in NO (<i>p</i> < 0.01) when the stage of CKD increased. In conclusion, patients with T2DM present higher levels of oxidative and inflammatory markers accompanied by a decrease in antioxidant defense. However, these oxidative status markers were associated with CKD stage progression in patients without T2DM. Thus, NO and SOD markers could help detect the early stages of CKD in patients who have not yet developed metabolic comorbidities such as T2DM.https://www.mdpi.com/1422-0067/23/19/11196chronic kidney diseaseoxidative stressdiabetes mellitusearly chronic kidney diseaseantioxidantsinflammation
spellingShingle Jorge Andrade-Sierra
Leonardo Pazarín-Villaseñor
Francisco Gerardo Yanowsky-Escatell
Elodia Nataly Díaz-de la Cruz
Andrés García-Sánchez
Ernesto Germán Cardona-Muñoz
Francisco Javier Munguía-Galaviz
Alejandra de Alba-Razo
Alejandra Guillermina Miranda-Díaz
The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus
International Journal of Molecular Sciences
chronic kidney disease
oxidative stress
diabetes mellitus
early chronic kidney disease
antioxidants
inflammation
title The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus
title_full The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus
title_fullStr The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus
title_full_unstemmed The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus
title_short The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus
title_sort influence of the severity of early chronic kidney disease on oxidative stress in patients with and without type 2 diabetes mellitus
topic chronic kidney disease
oxidative stress
diabetes mellitus
early chronic kidney disease
antioxidants
inflammation
url https://www.mdpi.com/1422-0067/23/19/11196
work_keys_str_mv AT jorgeandradesierra theinfluenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT leonardopazarinvillasenor theinfluenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT franciscogerardoyanowskyescatell theinfluenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT elodianatalydiazdelacruz theinfluenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT andresgarciasanchez theinfluenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT ernestogermancardonamunoz theinfluenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT franciscojaviermunguiagalaviz theinfluenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT alejandradealbarazo theinfluenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT alejandraguillerminamirandadiaz theinfluenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT jorgeandradesierra influenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT leonardopazarinvillasenor influenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT franciscogerardoyanowskyescatell influenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT elodianatalydiazdelacruz influenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT andresgarciasanchez influenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT ernestogermancardonamunoz influenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT franciscojaviermunguiagalaviz influenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT alejandradealbarazo influenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus
AT alejandraguillerminamirandadiaz influenceoftheseverityofearlychronickidneydiseaseonoxidativestressinpatientswithandwithouttype2diabetesmellitus